
TEVA PHARMACEUTICAL-SP ADR has reached an agreement in principle to settle long-running price-fixing litigation brought by 45 states across the United States, Washington, DC, and two territories.
Teva Pharmaceutical Industries has reached an agreement in principle to settle long running litigation with US states over generic drug price fixing allegations. The federal court put the case on hold following the deal. Terms of the settlement were not disclosed by the parties.

TEVA PHARMACEUTICAL-SP ADR has reached an agreement in principle to settle long-running price-fixing litigation brought by 45 states across the United States, Washington, DC, and two territories.
Everything you use on the web — faster, and in your pocket.